News

Burlington Stores Welcomes Michael Skirvin to Board of Directors

Burlington Stores Welcomes Michael Skirvin to Board of Directors

Burlington Stores Welcomes Michael Skirvin to Board of Directors

Burlington Stores, Inc., a leading off-price retailer in the United States, has recently announced an exciting development. The company has appointed Michael Skirvin to its Board of Directors, effective soon. This decision underscores the company's commitment to strengthening its leadership team and driving growth within the off-price retail sector.

A Strong Addition to Burlington's Leadership

John Mahoney, Chairman of the Board at Burlington, expressed his enthusiasm about the appointment. He stated, "Michael has a proven track record as a highly accomplished leader. We are pleased to welcome him to our Board." Mahoney highlighted that Skirvin's experience and insights would add immense value to Burlington’s ongoing strategic initiatives.

Insights from the CEO

The excitement around this appointment is shared by Michael O'Sullivan, the Chief Executive Officer of Burlington Stores. O'Sullivan remarked, "Having Michael on our Board brings over three decades of invaluable experience in the retail space, particularly in the off-price sector. His expertise will support our growth and strategic goals as we progress with the Burlington 2.0 strategy. We look forward to his contributions to our Company and shareholders."

Michael Skirvin's Background

Michael Skirvin isn't unfamiliar to the retail landscape. He served as Chief Executive Officer of Bob's Discount Furniture until 2020, where he significantly influenced the brand's growth. His journey in this industry began at The TJX Companies, where he held various important roles from 1989 to 2010, including Senior Vice President, Corporate Controller and Chief Operating Officer of the A.J. Wright division. His wealth of experience is expected to drive Burlington's leadership effectively.

Strategic Vision and Growth Potential

Skirvin's addition to the Board comes at a pivotal time for Burlington Stores, with the Company seeing robust growth in its operations and management. The off-price retail market continues to expand, and Burlington aims to leverage this momentum to enhance its brand presence. Skirvin's insights will play a crucial role in navigating emerging trends and consumer preferences in the retail environment.

About Burlington Stores, Inc.

Burlington Stores, Inc. operates a wide network of stores across multiple states, offering high-quality branded merchandise at reduced prices. The Company proudly recorded net sales of $10.6 billion in its recent fiscal year. With over 1,100 stores in operation, Burlington remains a Fortune 500 company recognized for its commitment to delivering exceptional value to its customers.

Looking Ahead

As Burlington continues to grow and innovate within the retail space, the collaboration between its seasoned leadership, including new board member Skirvin, is expected to contribute significantly to its strategic objectives and overall success. Burlington remains committed to showcasing high-quality apparel and merchandise while maintaining a strong focus on customer satisfaction and community involvement.

Investor Relations

For additional information about Burlington Stores, Inc., you can contact the Investor Relations team. David J. Glick and Daniel Delrosario are available to address queries at 855-973-8445. For inquiries via email, reach out to info@burlingtoninvestors.com for further assistance.

Frequently Asked Questions

What is the role of Michael Skirvin at Burlington Stores?

Michael Skirvin has been appointed to the Board of Directors and the Audit Committee at Burlington Stores.

What significant experience does Michael Skirvin bring?

Skirvin has over 30 years of experience in the retail sector, notably as the CEO of Bob's Discount Furniture and in various roles at The TJX Companies.

What is the focus of Burlington Stores?

Burlington Stores focuses on providing high-quality branded apparel and merchandise for the home at everyday low prices.

How does Burlington plan to grow?

The company aims to enhance its strategic initiatives through the insights and expertise of its newly appointed board members.

Where can I find more information on Burlington?

For more details, visit Burlington's official website or contact their Investor Relations team.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 308

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 9

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 26

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 321

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading

Top 5 Most Recently Viewed Articles

BioSyent Inc. to Announce Q3 Financial Results This Month

Updated Category News Views 189

BioSyent Inc. to Announce Q3 Financial Results BioSyent Inc., a prominent player in the specialty pharmaceutical industry, is preparing to release its financial results for the third quarter and year-to-date period. This important announcement is scheduled for November 20, prior to the market opening. The report will cover the company's performance for the three and nine...

Continue Reading
Dr. Ryan Egeland Joins Solventum as Chief Medical Officer

Updated Category News Views 381

Solventum Welcomes Dr. Ryan Egeland as New CMO Solventum, a pioneering healthcare company, recently announced the appointment of Dr. Ryan Egeland, MD, as their Chief Medical Officer. In this significant role, Dr. Egeland will lead the Global Medical and Clinical Affairs team, amplifying clinician and patient voices within the organization. Fostering Collaboration and...

Continue Reading
MiningToken Revolutionizes Cryptocurrency With AI Power

Updated Category News Views 186

Introducing MiningToken's Innovative AI Cloud Mining Service Bitcoin and Ethereum are experiencing remarkable market dynamics as Bitcoin persists in a bullish trend and Ethereum has gained notable ground recently. As global interest in cryptocurrencies grows, effective mining strategies are crucial for profitability. Amidst rising operational costs, many individuals seek...

Continue Reading
Saluda Medical's EVA™ Sensing Technology Approved in Europe

Updated Category News Views 111

Saluda Medical Achieves Regulatory Milestone with EVA™ Technology Saluda Medical, Inc. (ASX:SLD) has made significant strides in the medical device industry by achieving CE certification for its next-generation EVA™ Sensing Technology. This advancement not only marks a major endorsement in Europe but also is recognized in Australia. Following FDA approval in December...

Continue Reading
ReadPartner Inc. Unveils Revolutionary AI Tool to Combat Misinformation

Updated Category News Views 291

ReadPartner Inc. Launches AI Feature to Tackle Misinformation ReadPartner Inc., a leader in AI-driven media intelligence solutions, is excited to announce the upcoming launch of a groundbreaking digital security feature named ProfileScreen. This innovative tool aims to address the pressing issue of misinformation that plagues social media platforms. The ProfileScreen...

Continue Reading